| MeSH term | MeSH ID | Detail |
|---|---|---|
| Body Weight | D001835 | 333 associated lipids |
| Lung Neoplasms | D008175 | 171 associated lipids |
| Colonic Neoplasms | D003110 | 161 associated lipids |
| Hemolysis | D006461 | 131 associated lipids |
| Prostatic Neoplasms | D011471 | 126 associated lipids |
| Alzheimer Disease | D000544 | 76 associated lipids |
| Stomach Ulcer | D013276 | 75 associated lipids |
| Dermatitis, Contact | D003877 | 59 associated lipids |
| Thrombosis | D013927 | 49 associated lipids |
| Leukemia P388 | D007941 | 43 associated lipids |
| Ascites | D001201 | 25 associated lipids |
| Tuberculosis | D014376 | 20 associated lipids |
| Plaque, Amyloid | D058225 | 19 associated lipids |
| Vaginosis, Bacterial | D016585 | 10 associated lipids |
| Burkholderia Infections | D019121 | 7 associated lipids |
816-94-4
816-94-4 is a lipid of Glycerophospholipids (GP) class. 816-94-4 is associated with abnormalities such as Gigantism, Pulmonary Hypertension, Neutropenia, Serum Sickness and Urticaria. The involved functions are known as pulmonary effects, Hemodynamics, Stereochemistry, Host defense and Blood Circulation. 816-94-4 often locates in vesicle, Blood, biological membrane, soluble and Cardiopulmonary. The associated genes with 816-94-4 are pentaglobulin, EMILIN1 gene and FASTK Gene. The related lipids are Liposomes, dimyristoylphosphatidylglycerol, Lipopolysaccharides, Unilamellar Liposomes and Unilamellar Vesicles.
Cross Reference
Introduction
To understand associated biological information of 816-94-4, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with 816-94-4?
816-94-4 is suspected in Pulmonary Hypertension, Cholera, Gigantism, Neutropenia, Serum Sickness, Urticaria and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 816-94-4
PubChem Associated disorders and diseases
What pathways are associated with 816-94-4
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with 816-94-4?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with 816-94-4?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with 816-94-4?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with 816-94-4?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with 816-94-4?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with 816-94-4
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Anderson M et al. | Disposition of 3H-cholesteryl ether labeled liposomes following intravenous administration to mice: comparison with an encapsulated 14C-inulin as aqueous phase marker. | 2003 Jul-Sep | Drug Deliv | pmid:12944140 |
| Justo OR and Moraes AM | Incorporation of antibiotics in liposomes designed for tuberculosis therapy by inhalation. | 2003 Jul-Sep | Drug Deliv | pmid:12944141 |
| Briuglia ML et al. | Influence of cholesterol on liposome stability and on in vitro drug release. | 2015 | Drug Deliv Transl Res | pmid:25787731 |
| Wehbe M et al. | Development of a copper-clioquinol formulation suitable for intravenous use. | 2018 | Drug Deliv Transl Res | pmid:29247315 |
| Al Asmari AK et al. | Preparation, characterization, and in vivo evaluation of intranasally administered liposomal formulation of donepezil. | 2016 | Drug Des Devel Ther | pmid:26834457 |
| Alvarez-Figueroa MJ et al. | Use of DMPC and DSPC lipids for verapamil and naproxen permeability studies by PAMPA. | 2015 | Drug Dev Ind Pharm | pmid:24568608 |
| Ackerman DG and Feigenson GW | Lipid bilayers: clusters, domains and phases. | 2015 | Essays Biochem. | pmid:25658342 |
| Ogihara-Umeda I and Kojima S | Cholesterol enhances the delivery of liposome-encapsulated gallium-67 to tumors. | 1989 | Eur J Nucl Med | pmid:2598958 |
| Murata M et al. | Real-time in vivo imaging of surface-modified liposomes to evaluate their behavior after pulmonary administration. | 2014 | Eur J Pharm Biopharm | pmid:24055689 |
| Ingvarsson PT et al. | The surface charge of liposomal adjuvants is decisive for their interactions with the Calu-3 and A549 airway epithelial cell culture models. | 2014 | Eur J Pharm Biopharm | pmid:24726978 |
| Magarkar A et al. | A computational study suggests that replacing PEG with PMOZ may increase exposure of hydrophobic targeting moiety. | 2017 | Eur J Pharm Sci | pmid:28285174 |
| Pavelić Z et al. | Liposomes containing drugs for treatment of vaginal infections. | 1999 | Eur J Pharm Sci | pmid:10425385 |
| Kirjavainen M et al. | Influence of lipids on the mannitol flux during transdermal iontophoresis in vitro. | 2000 | Eur J Pharm Sci | pmid:10727874 |
| Song C et al. | Articaine interaction with DSPC bilayer: a 13C and 31P solid-state NMR study. | 2008 | Eur J Pharm Sci | pmid:18343644 |
| Han HK et al. | Improved oral bioavailability of alendronate via the mucoadhesive liposomal delivery system. | 2012 | Eur J Pharm Sci | pmid:22522117 |
| Konovalov O et al. | Lipid discrimination in phospholipid monolayers by the antimicrobial frog skin peptide PGLa. A synchrotron X-ray grazing incidence and reflectivity study. | 2002 | Eur. Biophys. J. | pmid:12355252 |
| Balvers WG et al. | Kinetics of cytochromes P-450 IA1 and IIB1 in reconstituted systems with dilauroyl- and distearoyl-glycerophosphocholine. | 1993 | Eur. J. Biochem. | pmid:8344304 |
| Lange LG et al. | Hemolysis of rat erythrocytes by replacement of the natural phosphatidylcholine by various phosphatidylcholines. | 1980 | Eur. J. Biochem. | pmid:6893690 |
| Rietjens IM et al. | On the role of phospholipids in the reconstituted cytochrome P-450 system. A model study using dilauroyl and distearoyl glycerophosphocholine. | 1989 | Eur. J. Biochem. | pmid:2496984 |
| Deleers M et al. | Inhibition by calcium antagonists of ionophore-mediated calcium transport in liposomes. | 1982 | Eur. J. Pharmacol. | pmid:6897041 |